Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Current Deferred Revenue (2016 - 2019)

CorMedix has reported Current Deferred Revenue over the past 5 years, most recently at $2206.0 for Q4 2019.

  • Quarterly results put Current Deferred Revenue at $2206.0 for Q4 2019, down 80.0% from a year ago — trailing twelve months through Dec 2019 was $2206.0 (down 80.0% YoY), and the annual figure for FY2019 was $2206.0, down 80.0%.
  • Current Deferred Revenue reached $2206.0 in Q4 2019 per CRMD's latest filing, down from $4400.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $132611.0 in Q2 2016 and bottomed at $2206.0 in Q4 2019.
  • Median Current Deferred Revenue over the past 5 years was $19870.0 (2016), compared with a mean of $52911.8.
  • The largest annual shift saw Current Deferred Revenue surged 291.98% in 2017 before it tumbled 87.52% in 2018.
  • Over 5 years, Current Deferred Revenue stood at $130409.0 in 2015, then fell by 20.09% to $104210.0 in 2016, then fell by 15.17% to $88404.0 in 2017, then crashed by 87.52% to $11029.0 in 2018, then tumbled by 80.0% to $2206.0 in 2019.
  • Business Quant data shows Current Deferred Revenue for CRMD at $2206.0 in Q4 2019, $4400.0 in Q3 2019, and $6618.0 in Q2 2019.